Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

This collaboration of seven observational clinical cohorts investigated risk factors for treatment-limiting toxicities in both antiretroviral-naive and experienced patients starting nevirapine-based combination antiretroviral therapy (NVPc). Patients starting NVPc after 1 January 1998 were included....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS 2009-08, Vol.23 (13), p.1689-1699
Hauptverfasser:	KESSELRING, Anouk M, WIT, Ferdinand W, MOCROFT, Amanda, SABIN, Caroline A, LUNDGREN, Jens D, GILL, M. John, GATELL, Jose M, RAUCH, Andri, MONTANER, Julio S, DE WOLF, Frank, REISS, Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active - adverse effects Antiretroviral Therapy, Highly Active - methods Antiviral agents Biological and medical sciences CD4 Lymphocyte Count Drug Hypersensitivity - etiology Female HIV Infections - drug therapy HIV Infections - immunology HIV Infections - mortality Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Male Medical sciences Middle Aged Nevirapine - adverse effects Nevirapine - therapeutic use Pharmacology. Drug treatments Retrospective Studies Risk Factors Treatment Outcome Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!